Köhne, C., & Hofheinz, R. (2012). First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. Journal of cancer research and clinical oncology, 138(1), . https://doi.org/10.1007/s00432-011-1061-6
Chicago-Zitierstil (17. Ausg.)Köhne, Claus-Henning, und Ralf-Dieter Hofheinz. "First-line Panitumumab Plus Irinotecan/5-fluorouracil/leucovorin Treatment in Patients with Metastatic Colorectal Cancer." Journal of Cancer Research and Clinical Oncology 138, no. 1 (2012). https://doi.org/10.1007/s00432-011-1061-6.
MLA-Zitierstil (9. Ausg.)Köhne, Claus-Henning, und Ralf-Dieter Hofheinz. "First-line Panitumumab Plus Irinotecan/5-fluorouracil/leucovorin Treatment in Patients with Metastatic Colorectal Cancer." Journal of Cancer Research and Clinical Oncology, vol. 138, no. 1, 2012, https://doi.org/10.1007/s00432-011-1061-6.